These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20927126)

  • 41. CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm.
    Munthe-Kaas MC; Carlsen KH; Helms PJ; Gerritsen J; Whyte M; Feijen M; Skinningsrud B; Main M; Kwong GN; Lie BA; Lødrup Carlsen KC; Undlien DE
    J Allergy Clin Immunol; 2004 Aug; 114(2):280-7. PubMed ID: 15316504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
    Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
    Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skin Reactivity to Aeroallergens in Schistosoma mansoni-Infected Brazilian Individuals and Modulation of CCL2 and IL-10.
    Correia do Nascimento WR; de Oliveira Nóbrega CG; Barros Lorena V; Alves Dos Santos P; de Souza Fernandes E; Maria Assis Costa V; Simões Barbosa C; Medeiros D; Sávio Sarinho E; Solé D; Maria Oliveira de Souza V
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):414-416. PubMed ID: 30530386
    [No Abstract]   [Full Text] [Related]  

  • 44. Association of IL10 promoter polymorphisms with idiopathic achalasia.
    Nuñez C; García-González MA; Santiago JL; Benito MS; Mearín F; de la Concha EG; de la Serna JP; de León AR; Urcelay E; Vigo AG
    Hum Immunol; 2011 Sep; 72(9):749-52. PubMed ID: 21641950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population.
    Kulmambetova G; Shtefanov I; Aitkulova A; Imanbekova M; Iskakova A; Makishev A; Ramankulov Y
    Bosn J Basic Med Sci; 2020 Nov; 20(4):539-546. PubMed ID: 32651972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-10 promoter polymorphisms in hepatitis C patients with and without Schistosoma mansoni co-infection.
    Abbas OM; Abdel-Rahman MH; Omar NA; Badran HM; Amir EM
    Liver Int; 2009 Oct; 29(9):1422-30. PubMed ID: 19555400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of SNP (-G1082A) IL-10 with increase in severity of periportal fibrosis in schistosomiasis, in the northeast of Brazil.
    Silva PC; Gomes AV; de Souza TK; Coêlho MR; Cahu GG; Muniz MT; Domingues AL
    Genet Test Mol Biomarkers; 2014 Sep; 18(9):646-52. PubMed ID: 25079344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-4 and STAT6 promoter polymorphisms but not interleukin-10 or 13 are essential for schistosomiasis and associated disease burden among Nigerian children.
    Adedokun SA; Seamans BN; Cox NT; Liou G; Akindele AA; Li Y; Ojurongbe O; Thomas BN
    Infect Genet Evol; 2018 Nov; 65():28-34. PubMed ID: 30010060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in the promoter region of IL10 gene are associated with virus etiology of infant bronchiolitis.
    Holster A; Teräsjärvi J; Vuononvirta J; Koponen P; Peltola V; Helminen M; He Q; Korppi M; Nuolivirta K
    World J Pediatr; 2018 Dec; 14(6):594-600. PubMed ID: 29802545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphisms of the cytokine genes TGFB1 and IL10 in a mixed-race population with Crohn's disease.
    Almeida NP; Santana GO; Almeida TC; Bendicho MT; Lemaire DC; Cardeal M; Lyra AC
    BMC Res Notes; 2013 Sep; 6():387. PubMed ID: 24074435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of genetic variation on innate immune activation in an environment with high infectious pressure.
    Boef AG; May L; van Bodegom D; Kuningas M; Eriksson UK; Westendorp RG
    Genes Immun; 2012 Feb; 13(2):103-8. PubMed ID: 21833021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphism in the IL10 promoter region and early markers of atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Heiskanen M; Kähönen M; Hurme M; Lehtimäki T; Mononen N; Juonala M; Hutri-Kähönen N; Viikari J; Raitakari O; Hulkkonen J
    Atherosclerosis; 2010 Jan; 208(1):190-6. PubMed ID: 19700159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk.
    Pereira WR; Kloos H; Crawford SB; Velásquez-Melendez JG; Matoso LF; Fujiwara RT; Cançado GG; Loverde PT; Correa-Oliveira R; Gazzinelli A
    Acta Trop; 2010 Jan; 113(1):34-41. PubMed ID: 19765542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-10 Gene Polymorphisms Are Associated with Post-Bronchiolitis Lung Function Abnormalities at Six Years of Age.
    Lauhkonen E; Koponen P; Teräsjärvi J; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Nuolivirta K; Toikka JO; Helminen M; He Q; Korppi M
    PLoS One; 2015; 10(10):e0140799. PubMed ID: 26473365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Common interleukin 10 polymorphism associated with decreased risk of tuberculosis.
    Shin HD; Park BL; Kim YH; Cheong HS; Lee IH; Park SK
    Exp Mol Med; 2005 Apr; 37(2):128-32. PubMed ID: 15886526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of serum levels of IL-9 and IL-17 in human Schistosoma mansoni infection and their relationship with periportal fibrosis.
    Barreto AV; Lacerda GA; Figueiredo AL; Diniz GT; Gomes EC; Domingues AL; Barbosa CS; Montengro SM; Morais CN
    Immunobiology; 2016 Dec; 221(12):1351-1354. PubMed ID: 27506138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis.
    Ouf EA; Ojurongbe O; Akindele AA; Sina-Agbaje OR; Van Tong H; Adeyeba AO; Kremsner PG; Kun JF; Velavan T
    J Infect Dis; 2012 Aug; 206(4):562-70. PubMed ID: 22693230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-Analysis of the Relation Between IL10 Promoter Polymorphisms and Autoimmune Liver Disease Risk.
    Qian BX; Ye Q; Zhao XY; Han T; Wang FM; Yang J
    Genet Test Mol Biomarkers; 2018 May; 22(5):302-313. PubMed ID: 29694797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian population.
    Barkhash AV; Kochneva GV; Chub EV; Romaschenko AG
    Microbes Infect; 2018 Mar; 20(3):212-216. PubMed ID: 29247709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Family-based association study of interleukin 10 (IL10) and interleukin 10 receptor alpha (IL10RA) functional polymorphisms in schizophrenia in Polish population.
    Kapelski P; Skibinska M; Maciukiewicz M; Pawlak J; Zaremba D; Twarowska-Hauser J
    J Neuroimmunol; 2016 Aug; 297():92-7. PubMed ID: 27397081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.